Serial exome analysis of disease progression in premalignant gammopathies

Leukemia

Volumn 28, Issue 7, 2014, Pages 1548-1552

  Zhao, S ^a,b   Choi, M ^a,b,c   Heuck, C ^d   Mane, S ^a,e   Barlogie, B ^d   Lifton, R P ^a,b,e   Dhodapkar, M V ^b,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c Seoul National University College of Medicine   (South Korea)

^d Myeloma Institute for Research and Therapy   (United States)

^e YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN P53;

CHROMOSOME 17; CHROMOSOME 8; COPY NUMBER VARIATION; DISEASE COURSE; EXOME; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL;

DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; EXOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; PARAPROTEINEMIAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS;

EID: 84904060605     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.59     Document Type: Letter

References (15)

1. Landgren O, Kyle RA, Rajkumar SV. From myeloma precursor disease to multiple myeloma new diagnostic concepts and opportunities for early intervention. Clin Cancer Res 2011 17 1243-1252.
2. Dhodapkar MV, Sexton R, Waheed S, Usmani S, Papanikolaou X, Nair B et al. Clinical, genomic and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120). Blood 2013 123 78-85.
3. Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer 2012 12 335-348.
4. Lopez-Corral L, Gutierrez NC, Vidriales MB, Mateos MV, Rasillo A, Garcia-Sanz R et al. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. Clin Cancer Res 2011 17 1692-1700.
5. Lopez-Corral L, Sarasquete ME, Bea S, Garcia-Sanz R, Mateos MV, Corchete LA et al. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status. Leukemia 2012 26 2521-2529.
6. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011 471 467-472.
7. Walker BA, Wardell CP, Melchor L, Hulkki S, Potter NE, Johnson DC et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(414) and t(1114) myeloma. Blood 2012 120 1077-1078.
8. Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S et al. Whole genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution and clonal tides. Blood 2012 120 1060-1066.
9. Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E et al. Clonal competition with alternating dominance in multiple myeloma. Blood 2012 120 1067-1076.
10. Weston-Bell N, Gibson J, John M, Ennis S, Pfeifer S, Cezard T et al. Exome sequencing in tracking clonal evolution in multiple myeloma following therapy. Leukemia 2013 27 1188-1191.
11. Walker BA, Wardell CP, Melchor L, Brioli A, Johnson DC, Kaiser MF et al. Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia 2013 28 384-90.
12. Neri A, Murphy JP, Cro L, Ferrero D, Tarella C, Baldini L et al. Ras oncogene mutation in multiple myeloma. J Exp Med 1989 170 1715-1725.
13. Chng WJ, Price-Troska T, Gonzalez-Paz N, Van Wier S, Jacobus S, Blood E et al. Clinical significance of TP53 mutation in myeloma. Leukemia 2007 21 582-584.
14. Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S et al. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood 2008 112 4235-4246.
15. Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012 366 1090-1098.